201620172018201920202021202220232024Billable/Specific CodeFemale Dx
- C56.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C56.9 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C56.9 – other international versions of ICD-10 C56.9 may differ.
ICD-10-CM C56.9 is grouped within Diagnostic Related Group(s):
- 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
- 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
- 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
- 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
- 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
- 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
- 754 Malignancy, female reproductive system with mcc
- 755 Malignancy, female reproductive system with cc
- 756 Malignancy, female reproductive system without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C56.9:
- unspecified site > duct
- female > unspecified site C56.9
- unspecified site > serous
- unspecified site > papillocystic
- unspecified site > pseudomucinous
- unspecified site > papillary
- unspecified site > malignant
- female > unspecified site C56.9
- unspecified site > malignant
- female > unspecified site C56.9
- unspecified site > endometrioid
- female > unspecified site C56.9
- unspecified site > Leydig cell (testis)
- female > unspecified site C56.9
- unspecified site > surface
- unspecified site > serous
- unspecified site > papillocystic
- unspecified site > pseudomucinous
- unspecified site > papillary
- unspecified site > surface, papillary
- female > unspecified site C62.90
- unspecified site > endometrioid
- female > unspecified site C56.9
- unspecified site > papillary
- unspecified site > mucinous
- unspecified site > mucinous
- unspecified site > pseudomucinous
- unspecified site > serous
- unspecified site > papillary
- unspecified site > papillary
- unspecified site > pseudomucinous
- unspecified site > papillary
- unspecified site > serous
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > borderline malignancy C56.-
- unspecified site > Dysgerminoma
- female > unspecified site C56.9
- unspecified site > carcinoma
- female > unspecified site C56.9
- female > unspecified site (male) C62.9-
- unspecified site > malignant
- female > unspecified site C56.9
- unspecified site > mucinous of low malignant potential
- unspecified site > mucinous of low malignant potential C56-
- unspecified site > serous of low malignant potential
- unspecified site > polyvesicular vitelline
- female > unspecified site C56.9
- unspecified site > serous of low malignant potential
- unspecified site > yolk sac
- female > unspecified site C56.9